Chemomab Therapeutics Ltd. - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Chemomab Therapeutics Ltd. - ADR
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
/ 
Frequently asked questions
To buy Chemomab Therapeutics Ltd. - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Chemomab Therapeutics Ltd. - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Chemomab Therapeutics Ltd. - ADR is CMMB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Chemomab Therapeutics Ltd. - ADR has its primary listing on NASDAQ (Small cap). You can trade Chemomab Therapeutics Ltd. - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Chemomab Therapeutics Ltd. - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Chemomab Therapeutics Ltd. - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Chemomab Therapeutics Ltd. - ADR.